Back to 
BlackRock, Inc.
BlackRock, Inc.
NBIX7 quarters
Position history for BlackRock, Inc.'s holdings in NEUROCRINE BIOSCIENCES INC
BlackRock, Inc. holds 13.7M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $2.3B as of 2026-Q2. The position was increased (+2.4% shares). NBIX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$2.3B
Current Shares
13.7M
Total Value Change
+$293M
Total Shares Change
-1.1M
Quarter-by-Quarter History
Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC